Experience

Davis Polk is advising V. F. Corporation in connection with its $120 million sale of its Contemporary Brands Coalition to Delta Galil Industries Ltd. The transaction, which is subject to…

Davis Polk advised the administrative agent in connection with a $200 million term loan facility (the “Credit Facility”) for Magellan Pharmacy Services, Inc., a wholly owned subsidiary of…

Davis Polk advised FormFactor, Inc. in connection with its acquisition of Cascade Microtech, Inc. pursuant to a merger agreement signed February 3, 2016. The former stockholders of Cascade…

Davis Polk advised Wuxi Construction and Development Investment Company Limited (無錫市建設發展投資有限公司) (the “Company”) in connection with the $300 million 3.25% guaranteed bonds due 2019 (the …

Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…

Davis Polk advised the joint book-running managers of an SEC-registered offering by co-issuers AmeriGas Partners, L.P. and AmeriGas Finance Corp. of $675 million aggregate principal amount…

Davis Polk is advising Perella Weinberg as financial adviser to HeartWare International, Inc. in connection with its $1.1 billion acquisition by Medtronic plc. Under the terms of the…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Universal American Corp. of an aggregate principal amount of $115 million of 4.00% convertible senior…

Davis Polk advised Communications Sales & Leasing, Inc. (“CS&L”) in connection with an underwritten public offering of 14,681,071 shares of common stock of CS&L (the …

Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…